Polarized macrophage functions are affected differentially after CSF-1R inhibition with PLX5622

Julia Barilo1, Nasry Zane Bouzeineddine1, Alecco Philippi1

  • 1Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, K7L 3N6, Canada.

PubMed

Insights

PLX5622, a CSF-1R inhibitor, impacts macrophage differentiation and survival in vitro. It affects M2a macrophage polarization but not M1-like macrophages, offering insights for in vitro studies.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Colony stimulating factor 1 receptor (CSF-1R) inhibitors, like PLX5622, are known to deplete microglial cells.
  • Recent in vivo studies suggest PLX5622 also affects macrophages (Mφ).

Purpose of the Study:

  • To investigate the in vitro effects of PLX5622 on the differentiation and functions of polarized macrophages derived from various tissues.
  • To understand the impact of CSF-1R signaling on macrophage polarization.

Main Methods:

  • Ex vivo isolation of macrophages from different tissues.
  • Treatment with PLX5622 at different stages of macrophage differentiation.
  • Assessment of macrophage viability, differentiation, and polarization (M1-like and M2a).

Main Results:

  • Early addition of PLX5622 post-isolation inhibited Mφ differentiation and survival.
  • PLX5622 addition after differentiation did not significantly impact Mφ viability.
  • PLX5622 altered functions and polarization of IL-4 (M2a) Mφ but not M1-like Mφ.

Conclusions:

  • PLX5622 influences Mφ differentiation and survival in vitro.
  • The CSF-1R inhibitor affects M2a polarization, providing a tool to study CSF-1R signaling in Mφ.
  • Findings offer novel applications for PLX5622 in in vitro macrophage research.